These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27453291)

  • 21. Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice.
    Beck G; Shinzawa K; Hayakawa H; Baba K; Sumi-Akamaru H; Tsujimoto Y; Mochizuki H
    PLoS One; 2016; 11(4):e0153789. PubMed ID: 27078024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-Target Effects in Transgenic Mice: Characterization of Dopamine Transporter (DAT)-Cre Transgenic Mouse Lines Exposes Multiple Non-Dopaminergic Neuronal Clusters Available for Selective Targeting within Limbic Neurocircuitry.
    Papathanou M; Dumas S; Pettersson H; Olson L; Wallén-Mackenzie Å
    eNeuro; 2019; 6(5):. PubMed ID: 31481399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased dopaminergic innervation in the brain of conditional mutant mice overexpressing Otx2: effects on locomotor behavior and seizure susceptibility.
    Tripathi PP; Di Giovannantonio LG; Sanguinetti E; Acampora D; Allegra M; Caleo M; Wurst W; Simeone A; Bozzi Y
    Neuroscience; 2014 Mar; 261():173-83. PubMed ID: 24384227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.
    Kärkkäinen E; Yavich L; Miettinen PO; Tanila H
    Brain Res; 2015 Oct; 1622():452-65. PubMed ID: 26168899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia.
    Hnasko TS; Perez FA; Scouras AD; Stoll EA; Gale SD; Luquet S; Phillips PE; Kremer EJ; Palmiter RD
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8858-63. PubMed ID: 16723393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-dependent alterations in behavior, drug responses and dopamine transporter expression in heterozygous DAT-Cre mice.
    Costa KM; Schenkel D; Roeper J
    Sci Rep; 2021 Feb; 11(1):3334. PubMed ID: 33558587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
    J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyperi Rhizoma inhibits the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reduction in nigrostriatal dopaminergenic neurons in estrogen-deprived mice.
    Kim HG; Hong J; Huh Y; Park C; Hwang DS; Choi JH; Oh MS
    J Ethnopharmacol; 2013 Jun; 148(1):322-8. PubMed ID: 23639362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic and Phenotypic Effects of AAV_Cre Used to Transduce Mesencephalic Dopaminergic Neurons.
    Erben L; Welday JP; Murphy R; Buonanno A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.
    Yu SJ; Airavaara M; Shen H; Chou J; Harvey BK; Wang Y
    Psychopharmacology (Berl); 2012 Jun; 221(3):479-92. PubMed ID: 22160138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal Neurons Partially Expressing a Dopaminergic Phenotype: Functional Significance and Regulation.
    Troshev D; Bannikova A; Blokhin V; Kolacheva A; Pronina T; Ugrumov M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
    Salvatore MF; Calipari ES; Jones SR
    ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system.
    Pan X; Guo X; Xiong F; Cheng G; Lu Q; Yan H
    Toxicol Lett; 2015 Jul; 236(1):60-8. PubMed ID: 25943760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
    Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
    Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.